Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma

Grégory Chevillard1, Marilene Paquet, Volker Blank

  • 1Lady Davis Institute for Medical Research and Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC, Canada.

Blood
|December 15, 2010
PubMed

Insights

Mice lacking the Nrf3 transcription factor showed increased susceptibility to cancer when exposed to benzo[a]pyrene. This suggests Nrf3 plays a protective role against chemical-induced lymphoma development.

Area of Science:

  • Molecular Biology
  • Toxicology
  • Oncology

Background:

  • NF-E2 p45 related factor 3 (Nrf3) is a transcription factor belonging to the cap 'n' collar family.
  • The in vivo function of Nrf3, particularly in chemical carcinogenesis, remains largely unexplored.

Purpose of the Study:

  • To investigate the role of Nrf3 in chemical-induced carcinogenesis.
  • To determine if Nrf3 deficiency influences susceptibility to benzo[a]pyrene (B[a]P)-induced tumors.

Main Methods:

  • Generation of Nrf3-deficient (Nrf3(-/-)) mice.
  • Exposure of wild-type and Nrf3(-/-) mice to the carcinogen benzo[a]pyrene (B[a]P).
  • Pathological analysis of tissues to assess tumor incidence and type.

Main Results:

  • Nrf3(-/-) mice exhibited significantly higher mortality rates compared to wild-type mice after B[a]P exposure.
  • A high incidence of T-cell lymphoblastic lymphoma was observed in B[a]P-treated Nrf3(-/-) mice.
  • Metastasis of lymphoblastic lymphoma to the lungs was noted in some Nrf3-deficient mice.

Conclusions:

  • The absence of Nrf3 predisposes mice to lymphoma development, indicating a protective role in hematopoietic malignancies.
  • Nrf3 plays a crucial role in preventing carcinogen-induced lymphomagenesis.
  • Nrf3-deficient mice represent a valuable preclinical model for studying lymphoma development.